Should You Obtain a PVR in This 72-Year-Old Man with Urinary Hesitation?
Yes, you should obtain a post-void residual (PVR) measurement in this patient before initiating or adjusting therapy. 1
Rationale Based on Guidelines
The most recent comprehensive guideline (2013) explicitly recommends PVR measurement as part of the specialized evaluation before embarking on any active therapy 1. While older AUA guidelines (2003) classified PVR as "optional" for medical therapy 2, the more recent evidence and expert consensus has elevated its importance, particularly in the context you describe.
Why PVR is Important in This Case
Key clinical factors that make PVR measurement particularly valuable here:
- Age 72 years: PVR volumes increase with age (approximately 0.65 mL per year) 3, making measurement more clinically relevant in older men
- Urinary hesitation: This voiding symptom correlates with higher PVR volumes in men 3 and should prompt objective assessment
- Pre-treatment baseline: PVR serves as both a diagnostic tool and a safety parameter for subsequent monitoring 1
What the PVR Will Tell You
The PVR measurement helps you:
Identify bladder dysfunction: Large PVR volumes (e.g., >350 mL) may indicate bladder dysfunction and predict slightly less favorable response to treatment 2
Detect disease progression risk: Elevated PVR may herald progression of disease and predict higher failure rates of watchful waiting 2
Guide treatment selection: While PVR doesn't predict response to alpha-blockers in the 0-300 mL range 2, it helps identify patients who may need more aggressive evaluation or intervention
Establish monitoring baseline: PVR should be repeated to improve precision due to marked intra-individual variability 1
Practical Measurement Approach
How to perform and interpret:
- Use noninvasive transabdominal ultrasonography 1
- Repeat the measurement to account for test-retest variability 2, 1
- Consider the PVR ratio (PVR/total bladder volume × 100): A ratio >12.9% predicts moderate-to-severe symptoms with reasonable accuracy 4, and >20% identifies voiding disorders with high sensitivity and specificity 5
Clinical Decision Points
Based on PVR results:
- PVR 0-200 mL: Generally safe to proceed with medical therapy; does not predict response to alpha-blockers 2
- PVR 200-350 mL: Proceed with caution; safety of noninvasive therapy not well-documented in this range 2
- PVR >350 mL: Suggests significant bladder dysfunction; consider urodynamic evaluation before invasive therapy 2
- PVR ratio >40%: May indicate combined bladder outlet obstruction and detrusor underactivity, warranting more extensive evaluation 5
Common Pitfalls to Avoid
Important caveats:
- No absolute cutoff mandates surgery: Even large PVR volumes are not contraindications to watchful waiting or medical therapy if the patient lacks UTI, renal insufficiency, or bothersome symptoms 2
- Don't rely on PVR alone: It must be interpreted within the broader clinical context, including symptom severity (IPSS), uroflowmetry (Qmax), and patient comorbidities 1, 6
- Account for variability: Single measurements can be misleading; repeat testing improves diagnostic precision 1
Integration with Other Tests
PVR works best when combined with:
- Uroflowmetry: Qmax <10 mL/sec suggests obstruction and increases likelihood of surgical benefit 2
- Symptom questionnaire (IPSS): Quantifies symptom burden and guides treatment intensity 7
- Urinalysis: Rules out infection or other pathology 8, 6
Bottom line: In this 72-year-old man with urinary hesitation, obtaining a PVR is a simple, noninvasive test that provides valuable diagnostic and prognostic information to guide your treatment decisions and establish a baseline for monitoring. The test should be repeated for accuracy and interpreted alongside other clinical parameters rather than in isolation.